Your browser doesn't support javascript.
loading
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
McGill, Janet B; Agarwal, Rajiv; Anker, Stefan D; Bakris, George L; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M; Birkenfeld, Andreas L; Caramori, Maria L; Brinker, Meike; Joseph, Amer; Lage, Andrea; Lawatscheck, Robert; Scott, Charlie; Rossing, Peter.
Afiliação
  • McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Agarwal R; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, Indiana, USA.
  • Anker SD; Department of Cardiology (CVK), Berlin, Germany.
  • Bakris GL; Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA.
  • Filippatos G; Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Ruilope LM; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain.
  • Birkenfeld AL; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Caramori ML; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.
  • Brinker M; Department of Diabetology, Endocrinology and Nephrology, University Clinic, Tübingen, Germany.
  • Joseph A; Institute for Diabetes Research and Metabolic Diseases of Helmholtz Center Munich, German Center of Diabetes Research (DZD e.V.), University of Tübingen, Tübingen, Germany.
  • Lage A; Diabetes & Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Lawatscheck R; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Scott C; Cardiology and Nephrology Clinical Development, Bayer AG, Wuppertal, Germany.
  • Rossing P; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany.
Diabetes Obes Metab ; 25(6): 1512-1522, 2023 06.
Article em En | MEDLINE | ID: mdl-36722675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos